Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
The Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting took place in Washington, D.C. and virtually from 13-15 October 2021. The world’s largest meeting dedicated solely to cancer immunotherapy brought together stakeholders across the field to share research breakthroughs and educational updates to improve outcomes for cancer patients.
VJOncology caught up with the presenters on new research studies and clinical trials!
🎥@ldawsonmd of @UofT discusses SBRT for localized colorectal cancers, emphasizing its potential to improve survival. SBRT should complement, not replace, surgery and systemic therapies:
🎥@AlexisLevee of @CityofHope discusses a study on gut microbiome's link to response in metastatic #breastcancer treated with ICIs. Future studies aim to personalize treatments and develop probiotics:
🎥@drlauragoff of @VUMC_Cancer discusses the CheckMate 9DW trial, showing nivolumab + ipilimumab improved OS in advanced HCC vs. sorafenib or lenvatinib, outperforming IMbrave150 and HIMALAYA trials:
🎥@ChiaraCrem1 of @Unipisa discusses HRQoL from the CheckMate 8HW study on first-line nivolumab + ipilimumab vs. chemo in MSI-H/dMMR mCRC. Checkpoint inhibitors improved HRQoL significantly:
The Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting took place in Washington, D.C. and virtually from 13-15 October 2021. The world’s largest meeting dedicated solely to cancer immunotherapy brought together stakeholders across the field to share research breakthroughs and educational updates to improve outcomes for cancer patients.
VJOncology caught up with the presenters on new research studies and clinical trials!
🎥@ldawsonmd of @UofT discusses SBRT for localized colorectal cancers, emphasizing its potential to improve survival. SBRT should complement, not replace, surgery and systemic therapies:
🎥@AlexisLevee of @CityofHope discusses a study on gut microbiome's link to response in metastatic #breastcancer treated with ICIs. Future studies aim to personalize treatments and develop probiotics:
🎥@drlauragoff of @VUMC_Cancer discusses the CheckMate 9DW trial, showing nivolumab + ipilimumab improved OS in advanced HCC vs. sorafenib or lenvatinib, outperforming IMbrave150 and HIMALAYA trials:
🎥@ChiaraCrem1 of @Unipisa discusses HRQoL from the CheckMate 8HW study on first-line nivolumab + ipilimumab vs. chemo in MSI-H/dMMR mCRC. Checkpoint inhibitors improved HRQoL significantly:
Breast Cancer Sessions: Highlights from SABCS 2021
Join Lisa A. Carey (UNC Lineberger, Chapel Hill, NC) and Aleix Prat (Hospital Clínic Barcelona, Barcelona, Spain) as they discuss the latest advances in breast cancer presented at the San Antonio Breast Cancer Symposium (SABCS) 2021 and what the latest research means for the clinic.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.